| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GridAI Technologies Corp. | Chief Executive Officer, Director | Common Stock | 40,000 | $24,000 | $0.6000 | 22 Dec 2025 | Direct |
| LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Director | Options to Purchase Common Stock | 25,000 | 15 Aug 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ENTO | GridAI Technologies Corp. | 22 Dec 2025 | 1 | $0 | 4 | Chief Executive Officer, Director | 29 Dec 2025, 17:59 |
| LIXT | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | 15 Aug 2025 | 1 | $0 | 4 | Director | 18 Aug 2025, 15:00 |
| ENTO | Entero Therapeutics, Inc. | 11 Aug 2025 | 0 | $0 | 3 | Director | 18 Aug 2025, 18:56 |
| LIXT | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | 18 Jul 2025 | 0 | $0 | 3 | Director | 21 Jul 2025, 16:37 |